Japanese Generic Market Forecast to 2013

Date: March 22, 2011
Pages: 45
Price:
US$ 800.00
Publisher: RNCOS E-Services Pvt. Ltd.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: J8931BD54F4EN
Leaflet:

Download PDF Leaflet

Japanese Generic Market Forecast to 2013
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00


Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other rights. Usually, generic drugs are as effective as their master drugs and become available to patients at a very low cost. Due to their low price nature, generic drugs are being used across the world and the governments are devising strategies to make them more accessible to society.

Japan is one of the leading pharmaceutical markets in the world; however, the share of generics has been low. Public perception is the key factor for such a low share. However, the government has played a vital role in promoting generic drugs across the country by spreading awareness regarding benefits and quality. Good promotional activities have largely benefitted Japanese generics market during the past few years and with total size of around US$ 8 Billion in 2010, the market is poised to grow at a fast pace. The patent expiry of branded drugs and active ingredients will act as growth drivers for the market in future and the government support will strengthen market potential.

Currently, the Japanese generics market is characterized by the presence of major global pharmaceutical players. These players have been devising strategies and making alliances with domestic manufacturers to enlarge their market share. Companies, such as Pfizer, Merck, Sandoz etc. are likely to play a prominent role in expanding generic drugs market in Japan in near future. The role of NHI pharmacies and DPC hospitals is also being valued as exceptional in the positive industry developments. Focus on strong marketing and cardiovascular generics are the trends positively affecting market in an effective manner.

The report “Japanese Generic Market Forecast to 2013” provides an in-depth research and prudent analysis on the generic market in Japan. It analyzes the current trends prevailing in the generic market and investigates their impact on the future shape of the industry. The report also covers the performance of key players in the Japanese generic markets. Moreover, based on various present and future indicators, the future scenario of the market has been analyzed and presented in the report.
1. ANALYST VIEW

2. THE JAPANESE PHARMACEUTICAL MARKET: OVERVIEW

3. RECENT MARKET TRENDS

3.1 Important Role of NHI Pharmacies and DPC Hospitals
3.2 Expansion of Foreign Generic Drugs Manufacturers
3.3 Quality Driven Approach in Market
3.4 Cardiovascular Generic Drugs
3.5 Renowned Focus on Marketing

4. THE JAPANESE GENERIC DRUGS MARKET

4.1 Industry Overview
4.2 Market Segmentation
4.3 Distribution Channels
4.4 Key Manufacturers
4.5 Therapeutic Segment

5. CONSUMER BEHAVIOR ANALYSIS

6. REGULATORY ENVIRONMENT

7. OPPORTUNITY ASSESSMENT: GENERIC DRUGS MARKET

8. KEY PLAYERS

8.1 Sawai Pharmaceuticals
8.2 Nichi-Iko
8.3 Towa
8.4 Nippon Chemiphar
8.5 Fuji Pharma
8.6 Taiyo Pharmaceutical

LIST OF FIGURES:

Figure 2-1: Pharmaceutical Market (Trillion ¥), 2009-2013
Figure 2-2: Pharmaceutical Market by Segment (%), 2010
Figure 4-1: Share of Generic Drugs in Pharmaceuticals Market w.r.t to Developed Countries (2008)
Figure 4-2: Asia Pacific - Share of Countries in Generic Drugs Market (2010)
Figure 4-3: Generic Drugs Market (Billion US$), 2009-2013
Figure 4-4: Generic Drugs Market by Segment (%), 2009
Figure 4-5: Generic Drugs Market by Medical Institution (%), 2008 & 2009
Figure 4-6: Number of DPC Hospitals (FY 2007 to FY 2009)
Figure 4-7: Generic Drugs Market by Distribution Channel (%), 2008 & 2009
Figure 4-8: Market Share of Generic Drugs Manufacturers (2009)
Figure 6-1: Share of Generic Drugs in Pharmaceuticals Market (Sep 2009 & Mar 2013)
Figure 7-1: Generic Drugs Penetration Rate (2005-06 to 2008-09)
Figure 8-1: Sawai Pharmaceutical - Sales by Therapeutic Category (%), H1 FY 2010
Figure 8-2: Towa Pharmaceutical - Sales by Therapeutic Category (%), Mar 2010

LIST OF TABLES:

Table 3-1: Key Foreign Generic Drugs Manufacturers in Japan
Table 4-1: Forecast for Key Macroeconomic Indicators
Table 4-2: Key Tie-ups & Alliances in Generic Drugs Market (2008-2010)
Table 4-3: Generic Drugs Prescriptions by Therapeutic Category (%)
Table 6-1: Key Measures for Generic Drugs Promotion
Table 7-1: Patent Expiry of Key Active Ingredients (2011 & 2012)
Skip to top


Ask Your Question

Japanese Generic Market Forecast to 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: